摘要
目的：探讨甲硝唑联合莫西沙星治疗肺脓肿的临床探析。方法选取2013年11月～2014年11月我院接诊的45例肺脓肿患者，按照入院的先后顺序分为25例实验组和20例对照组，对照组采用甲硝唑联合头孢哌酮舒巴坦，实验组采用甲硝唑联合莫西沙星，观察两组患者的治疗效果。结果实验组患者的治疗有效率、退热时间、血常规恢复时间、住院天数及不良反应的发生率明显优于对照组，差异显著，有统计学意义（P〈0.05）。结论 甲硝唑联合莫西沙星治疗肺脓肿的临床治疗效果显著，有效提高患者的治疗有效率，缩短退热时间、血常规恢复时间及住院天数。
Objective Clinical study on metronidazole combined with moxifloxacin in treatment of lung abscess is to be investigated.Methods Choose 45 patients of lung abscess who are treated in hospital from November 2013 to November 2014 and separate them into study group with 25 patients and control group with 20 patients according to their hospitalization sequence; patients in control group are given metronidazole combined with cefoperazone sulbactam medication treatment,while patients in study group are given metronidazole combined with moxifloxacin medication treatment; and then compare treatment effects between two groups.Results Patients’ treatment efficiency and fever-abatement time,recovery time of CBC（complete blood count）and their hospitalization days and side-effect incidence in study group are much more favorable than counterparts in control group; there is a differential between two groups and such a result has statistic value（P〈0.05）.Conclusion Metronidazole combined with moxifloxacin is of clinical efficiency in treatment of lung abscess; it is conducive to increasing treatment efficiency and shortening patients’ fever-abatement time,recovery time of CBC（complete blood count）and their hospitalization days; thus,such a medication treatment is quite worthwhile to be promoted widespread.
出处
《中国卫生标准管理》
2015年第5期254-256,共3页
China Health Standard Management
关键词
甲硝唑
莫西沙星
肺脓肿
临床探析
Metronidazole
Moxifloxacin
Lung abscess
Clinical study
